Moderna has joined the UK’s BioIndustry Association (BIA), taking the trade association’s membership to over 500 companies.

A new disease surveillance project to curb the spread of known and unknown pathogens, especially mosquito-borne illnesses, has been launched by GSK and Microsoft in Nepal.

The World Health Organization (WHO) has granted the first prequalification for a malaria vaccine to GSK’s Mosquirix in an important step toward immunising children against the disease.

The injectable HIV treatment cabotegravir is set to become more widely available in sub-Saharan Africa following a new licensing agreement.

Sanofi has joined the ‘Beacon of Hope’ programme – a Novartis initiative seeking to address racial inequality in clinical trials, health and education and to create greater diversity across R&D structures.

The Association of the British Pharmaceutical Industry (ABPI) has been awarded PIF TICK trusted healthcare information creator status by the Patient Information Forum, in recognition of its commitment to providing clear, accurate information for patients and the public

In its annual Palio meeting, GSK discusses the growing threat to human health from infectious disease with a group of experts in immunology, vaccinology and epidemiology.

CEPI, Gavi and WHO have announced a collective effort to support the Ugandan Government’s response to the recent Ebolavirus outbreak.